Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients

Kidney International

Volumn 57, Issue 2, 2000, Pages 632-638

  Wong, Teresa Yuk Hwa ^a   Poon, Peter ^a   Szeto, Cheuk Chun ^a   Chan, Julianna Chung Ngor ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Angiotensin converting enzyme gene; Gene polymorphism; PAI 1 gene; Type 2 diabetes mellitus

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; EXTRACELLULAR MATRIX; FIBRINOLYSIS; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033935856     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00884.x     Document Type: Article

References (24)

1. 1. UKPDS: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): UK Prospective Diabetes Study (UKPDS) Group. Lancet 12:837-853, 1998
2. 2. KUNZ R, BORK JP, FRITSCHE L, RINGEL J, SHARMA AM: Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy: A methodological appraisal and systematic review. J Am Soc Nephrol 9:1653-1663, 1998
3. 3. SCHMIDT S, GIEBEL R, BERGIS KH, STROJEK K, GRZESZCZAK W, GANTEN D, RITZ E, THE DIABETIC NEPHROPATHY STUDY GROUP: angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. Nephrol Dial Transplant 11:1766-1761, 1996
4. 4. FOGARTY DG, HARRON JC, HUGHES AE, NEVIN NC, DOHERTY CC, MAXWELL AP: A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45:1204-1208, 1996
5. 5. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
6. 6. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/ plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
7. 7. ANGLES-CANO E, RONDEAU E, DELARUE F, HAGEGE J, SULTAN Y, SRAER JD: Identification and cellular localization of plasminogen activator of the human glomeruli. Thromb Haemost 54:688-692, 1985
8. 8. DAWSON S, HAMSTEN A, WIMAN B, HENNEY A, HUMPHRIES S: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasminogen activator inhibitor-1 activity. Arterioscler Thromb 11:183-190, 1991
9. 9. KIMURA H, GEJYO F, SUZUKI Y, SUZUKI S, MIYAZAKI R, ARAKAWA M: Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy. Kidney Int 54:1659-1669, 1998
10. 10. CHEUNG CK, SWAMINATHAN R: Rapid economical immuno-turbidimetric method for albuminuria. Clin Chem 33:204-205, 1987
11. 11. FALK G, SVENSSON H, ALMQVISI Å, WIMAN B: Allele specific PCR for detection of a sequence polymorphism in the promoter region of the plasminogen activator inhibitor-1 (PAI-1) gene. Fibrinolysis 8(Suppl 1):45-47, 1994
12. 12. YE S, GREEN FR, SCARABIN PY, NICAUD V, BARA L, DAWSON SJ, HUMPHRIES SE, EVANS A, LUC G, CAMBOU JP, ARVEILLER D, HENNEY AM, COMBIEN F: The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 74:837-841, 1995
13. 13. PANAHLOO A, MOHAMED-ALI VIDYA LANE A, GREEN F, HUMPHRIES SE, YUDKIN JS: Determinants of plasminogen activator inhibitor-1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor-1 gene. Diabetes 44:37-12, 1995
14. 14. DAWSON SJ, WIMAN B, HAMSTEN A, GREEN F, HUMPHRIES S, HENNEY AM: The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745, 1993
15. 15. MANSFIELD MS, STICKLAND MH, GRANT PJ: Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in NIDDM. Thromb Haemost 74:1032-1034, 1995
16. 16. MANSFIELD MW, STICKLAND MH, GRANT PJ: Environmental and genetic factors in relation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with NIDDM. Thromb Haemost 74:842-847, 1995
17. 17. KIM DK, KIM JW, KIM S, GWON HC, RYU JC, HUH JE, CHOO JA, CHOI Y, RHEE CH, LEE WR: Polymorphisms of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 17:3242-3247, 1997
18. 18. BROWN NF, AGIRBASLI MA, WILLIAMS GH, HITCHFIELD WR, VAUGHAN DE: Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 32:965-971, 1998
19. 19. OIKAWA T, FREEMAN M, LO W, VAUGHAN KE, FOGO A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 51:164-172, 1997
20. 20. WONG TYH, CHAN JCN, POON E, LI PKT: Lack of association of angiotensin converting enzyme (DD/II) & angiotensinogen M235T gene polymorphism with renal function among type 2 diabetic patients in Chinese. Am J Kidney Dis 33:1064-1070, 1999
21. 21. NAGI DK, MCCORMACK LJ, MOHAMED-ALI V, YUDKIN JS, KNOWLER WC, GRANT PJ: Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes. Diabetes Care 20:1304-1309, 1997
22. 22. MANSFIELD MS, STICKLAND MH, CARTER AM, GRANT PJ: Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy. Thromb Haemost 71:731-736, 1994
23. 23. LANDER E, SCHORK N: Genetic dissection of complex traits. Science 265:2037-2048, 1994
24. 24. CHAN JCN, CHEUNG CK, SWAMINATHAN R, NICHOLLS MG, COCKRAM CS: Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus. Postgrad Med J 69:204-210, 1993